clinical trial · NCT02024152
Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg
JDP Therapeutics, Inc.·phase1·completed·n = 24
Acute UrticariaJDP-205 IV high doseJDP-205 IV low doseJDP-205 IMControl: Zyrtec
brief summary
This study is to investigate the pharmacokinetics (PK) together with the safety and tolerability of JDP-205 at 5 mg and 10 mg intravenous doses and 10 mg intramuscular dose, in comparison to the marketed cetirizine oral product Zyrtec® 10 mg tablets (an OTC product) in healthy male and female volunteers after a single dose administration.
started
Mar 1, 2011
primary completion
Jul 1, 2011
completion
Jul 1, 2011
last updated
Mar 6, 2024
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol